When I tried to understand why the weight loss difference is so large, the answer kept coming back to the glucagon component
Read the blog: #GLP1 #RealWorldData #RWE #HEOR To view or add a comment, sign in More Relevant Posts GLP1s are Booming, but building Trust and Cognition will be Challenging moving forward At JPM26, two signals around GLP-1s stood out: 1) 1.5 million patients are turning to compounded, unapproved GLP1s because approved options feel too expensive or inaccessible
Clinical studies have also verified augmented glucose-lowering action of this combination in association with low risk for hypoglycemia (115, 143, 144)
Fan H, Gong N, Li TF, Ma AN, Wu XY, Wang MW, Wang YX (2015) The non-peptide GLP-1 receptor agonist WB4-24 blocks inflammatory nociception by stimulating beta-endorphin release from spinal microglia